Related references
Note: Only part of the references are listed.Association of amyloid-beta CSF/PET discordance and tau load 5 years later
Juhan Reimand et al.
NEUROLOGY (2020)
Amyloid-β PET and CSF in an autopsy-confirmed cohort
Juhan Reimand et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Assessment of 18F-Florbetaben Amyloid PET Imaging in Patients with Suspected Alzheimer's Disease and Isolated Increase in Cerebrospinal Fluid Tau Proteins
Chloe Manca et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an A42 concentration in the very high range: a prospective study
Chloe Manca et al.
JOURNAL OF NEUROLOGY (2019)
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Arno de Wilde et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
Juhan Reimand et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Added value of F-18-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study
Mathieu Ceccaldi et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia
Matthew Davis et al.
CURRENT ALZHEIMER RESEARCH (2018)
Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
Christelle Gervaise-Henry et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
Sebastian Palmqvist et al.
NATURE COMMUNICATIONS (2017)
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Andrei G. Vlassenko et al.
ANNALS OF NEUROLOGY (2016)
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study
Marina Boccardi et al.
JAMA NEUROLOGY (2016)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri et al.
ALZHEIMERS & DEMENTIA (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
Neurocognitive Disorders in DSM-5
Dan Blazer
AMERICAN JOURNAL OF PSYCHIATRY (2013)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Share Paper
